Page 322 - Tata_Chemicals_yearly-reports-2019-20

Notice

NOTICE IS HEREBY GIVEN THAT THE EIGHTY-FIRST (81 ) Companies (appointment and Qualification of directors)
st
ANNUAL GENERAL MEETING OF THE MEMBERS OF TATA rules, 2014, as amended from time to time and SeBI (listing
CHEMICALS LIMITED will be held on tuesday, July 7, 2020 at obligations and disclosure requirements) regulations, 2015
3.00 p.m. (ISt) via two-way Video Conferencing (‘VC’) facility or other (‘listing regulations’), as amended from time to time, the
audio visual means (‘oaVM’) to transact the following businesses: appointment of dr. natraj, who has submitted a declaration
that he meets the criteria for independence as provided in
Ordinary Business Section 149(6) of the act and rules framed thereunder and

1. to receive, consider and adopt the audited Standalone regulation 16(1)(b) of the listing regulations, as amended,
Financial Statements of the Company for the financial year and who is eligible for appointment as an Independent
ended March 31, 2020, together with the reports of the director of the Company, not liable to retire by rotation, for a
Board of directors and auditors thereon. term of 5 (five) consecutive years commencing from august
8, 2019 to august 7, 2024 (both days inclusive), be and is
2. to receive, consider and adopt the audited Consolidated hereby approved.”
Financial Statements of the Company for the financial year
ended March 31, 2020, together with the report of the 6. Appointment of Mr. K. B. S. Anand (DIN: 03518282) as a
auditors thereon. Director and as an Independent Director of the Company
3. to declare dividend on the ordinary Shares for the financial to consider and if thought fit, to pass the following resolution
year ended March 31, 2020. as an ordinary resolution:
4. to appoint a director in place of Mr. r. Mukundan “RESOLVED THAT Mr. K. B. S. anand (dIn: 03518282) who was
(dIn: 00778253), who retires by rotation and being eligible, appointed as an additional director of the Company with
offers himself for re-appointment. effect from october 15, 2019 by the Board of directors and
who holds office up to the date of the forthcoming annual
Special Business general Meeting of the Company in terms of Section 161(1)
5. Appointment of Dr. C. V. Natraj (DIN: 07132764) as a of the Companies act, 2013 (‘the act’), but who is eligible
Director and as an Independent Director of the Company for appointment and in respect of whom the Company has
received a notice in writing from a Member under Section
to consider and if thought fit, to pass the following resolution 160(1) of the act proposing his candidature for the office of
as an ordinary resolution:
a director, be and is hereby appointed as a director of the
“RESOLVED THAT dr. C. V. natraj (dIn: 07132764) who was Company.
appointed as an additional director of the Company with
effect from august 8, 2019 by the Board of directors and RESOLVED FURTHER THAT pursuant to the provisions
who holds office up to the date of the forthcoming annual of Sections 149, 150 and 152 read with Schedule IV and
general Meeting of the Company in terms of Section 161(1) other applicable provisions of the act [including any
of the Companies act, 2013 (‘the act’), but who is eligible statutory modification(s) or re-enactment(s) thereof], the
for appointment and in respect of whom the Company has Companies (appointment and Qualification of directors)
received a notice in writing from a Member under Section rules, 2014, as amended from time to time and SeBI (listing
160(1) of the act proposing his candidature for the office of obligations and disclosure requirements) regulations, 2015
a director, be and is hereby appointed as a director of the (‘listing regulations’), as amended from time to time, the
Company. appointment of Mr. anand, who has submitted a declaration
that he meets the criteria for independence as provided in
RESOLVED FURTHER THAT pursuant to the provisions Section 149(6) of the act and rules framed thereunder and
of Sections 149, 150 and 152 read with Schedule IV and regulation 16(1)(b) of the listing regulations, as amended,
other applicable provisions of the act [including any and who is eligible for appointment as an Independent
statutory modification(s) or re-enactment(s) thereof], the director of the Company, not liable to retire by rotation, for a

320 I Integrated annual report 2019-20